Friends of Cancer Research Hill Briefing on FDA

Realizing the Return on Investment of Biomedical Research Science and Progress at the Food and Drug FDA This briefing is being held in conjunction with the release of a study in Health Affairs conducted by Friends of Cancer Research that compares approval rates of cancer drugs by the U.S. Food and Drug Administration versus its Europe